1Chantal Autexier.Telomerase as a possible target for anticancer therapy,Chemistry&biology,1999,6,11:299-303.
2Francois Lavelle,et al.Telomerase:a therapeutic target for the third millennium,Critical Reviews in Oncology/Hematology,2000,34:111-126.
3Haiyong han,Laurence H.Hurley,G-quadrplex DNA:a potential target for anti-cancer drug design,Tips,2000,21:136-142.
4Sun D,et al,Inhibition of human telomerase by a G-quaruplex-interactive compound,J.Med.Chem,1997,40:2113-2116.
5Read M.A,et al.Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors:structure-activity relationships,J.Med.Chem,1999,42:4538-4546.
6Briem H,et al.Molecular similarity based on DOCK generated fingerprints,J.Med.Chem,1996,39:3401-3408.
7Guo Q,et al.Ineraction of the dye ethdium bromide with DNA containing guanine repeats,Biochemistry,1992,31:2451.
8Harrisom R.J,et al.Human telomerase inhibiton by substituted acridine derivatives,Bioorg.Med.Chem.Lett,1999,9:2463-2468.
9Vittorio Caprio,et al.Anovel inhibitor of human telomerase derived from 10H-Indolo[3,2-b]quiunoline,Bioorg.Med.Chem.Lett,2000,10:2063-2066.
10Perry P.J,et al.Design,synthesis,and evaluation of human telomerase inhibitiors based upon a tetracyclic structure motif,Anti-Cancer Design,1999,14:373-382.
